Midkine promotes thyroid cancer cell migration and invasion by activating the phosphatidylinositol 3 kinase/protein kinase B/mammalian target of rapamycin pathway
Our findings confirmed that MDK promotes TC migration and invasion by activating PAmT-P. MDK is a novel molecular target for the treatment of patients with metastatic TC.
Authors
- Liqing Jiang (ORCID: https://orcid.org/0000-0002-2595-9109)
- Yongfeng Zhao (ORCID: https://orcid.org/0000-0003-2962-7504)
- Wengang Liu (ORCID: https://orcid.org/0000-0002-8887-8429)
- Ping Zhou (ORCID: https://orcid.org/0009-0007-9923-9220)
- Yuan Li (ORCID: https://orcid.org/0000-0001-8266-0771)
- Mengwen Xia
Institutions
- Central South University (CN)
- Third Xiangya Hospital (CN)
Publication Details
- Journal
- CytoJournal
- Published
- 2024-11-15
- DOI
- https://doi.org/10.25259/cytojournal_47_2024
- Citations
- 3
- Primary Topic
- Proteoglycans and glycosaminoglycans research
- Type
- article
- Field-Weighted Citation Impact
- 0.98